Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 975

1.

Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.

Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L, Rigas B.

Mol Cancer Ther. 2006 Jun;5(6):1530-8.

3.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.

Cancer Res. 2000 Jan 15;60(2):293-7.

4.

Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.

Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.

Cancer Res. 2001 May 1;61(9):3647-52.

5.

Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.

Rao CV, Hirose Y, Indranie C, Reddy BS.

Cancer Res. 2001 Mar 1;61(5):1927-33.

6.

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.

Reddy BS, Rao CV, Rivenson A, Kelloff G.

Carcinogenesis. 1993 Aug;14(8):1493-7.

PMID:
8353834
7.

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

Rao CV, Kawamori T, Hamid R, Reddy BS.

Carcinogenesis. 1999 Apr;20(4):641-4.

PMID:
10223193
8.

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

Kawamori T, Rao CV, Seibert K, Reddy BS.

Cancer Res. 1998 Feb 1;58(3):409-12.

9.

Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.

Janakiram NB, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2009 Jan;2(1):52-9. doi: 10.1158/1940-6207.CAPR-08-0140.

11.
12.
13.

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.

Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV.

Cancer Res. 2006 Apr 15;66(8):4542-6.

14.

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R.

Cancer Res. 1997 Jul 15;57(14):2909-15.

15.

Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets.

Reddy BS, Rivenson A, El-Bayoumy K, Upadhyaya P, Pittman B, Rao CV.

J Natl Cancer Inst. 1997 Apr 2;89(7):506-12.

PMID:
9086007
16.

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.

Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H.

Jpn J Cancer Res. 1997 Sep;88(9):821-30.

PMID:
9369929
18.

Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.

Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, el-Bayoumy K.

Cancer Res. 1992 Oct 15;52(20):5635-40.

19.

Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis.

Kawamori T, El-Bayoumy K, Ji BY, Rodriguez JG, Rao CV, Reddy BS.

Int J Oncol. 1998 Jul;13(1):29-34.

PMID:
9625800
20.

Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.

Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS.

Cancer Res. 1993 Sep 15;53(18):4182-8.

Supplemental Content

Support Center